|Institutional Source||Beutler Lab|
|Gene Name||lysine (K)-specific methyltransferase 2C|
|Synonyms||Mll3, E330008K23Rik, HALR|
|Is this an essential gene?||Probably essential (E-score: 0.882)|
|Stock #||R4377 (G1)|
|Chromosomal Location||25271798-25498786 bp(-) (GRCm38)|
|Type of Mutation||missense|
|DNA Base Change (assembly)||C to T at 25315326 bp|
|Amino Acid Change||Valine to Isoleucine at position 1929 (V1929I)|
|Ref Sequence||ENSEMBL: ENSMUSP00000043874 (fasta)|
|Gene Model||predicted gene model for transcript(s): [ENSMUST00000045291]|
|Predicted Effect||probably benign
AA Change: V1929I
PolyPhen 2 Score 0.002 (Sensitivity: 0.99; Specificity: 0.30)
AA Change: V1929I
|Meta Mutation Damage Score||0.064|
|Coding Region Coverage||
|Validation Efficiency||98% (57/58)|
FUNCTION: [Summary is not available for the mouse gene. This summary is for the human ortholog.] This gene is a member of the myeloid/lymphoid or mixed-lineage leukemia (MLL) family and encodes a nuclear protein with an AT hook DNA-binding domain, a DHHC-type zinc finger, six PHD-type zinc fingers, a SET domain, a post-SET domain and a RING-type zinc finger. This protein is a member of the ASC-2/NCOA6 complex (ASCOM), which possesses histone methylation activity and is involved in transcriptional coactivation. [provided by RefSeq, Jul 2008]
PHENOTYPE: Mice homozygous for a knock-out allele display partial embryonic lethality, delayed eyelid opening, postnatal growth retardation, impaired fertility in both sexes, and decreased proliferation of cultured mouse embryonic fibroblasts. [provided by MGI curators]
|Allele List at MGI|
|Other mutations in this stock||
|Other mutations in Kmt2c||
(F):5'- GTAAAGTGATCACTGGTTCCAGTTG -3'
(R):5'- AGCCACCTTCTCCACAGATG -3'
(F):5'- CTTTGTTCTGAAATCACAGGGGAC -3'
(R):5'- ACAGATGTTCTCACCTGGATC -3'
|Posted On||Jul 06, 2015|